 | • レポートコード：MRC2-11QY12575 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は吸収不良症候群のグローバル市場について調査・分析したレポートです。種類別（乳糖不耐症、嚢胞性線維症、ウィップル病、寄生虫症、熱帯性スプルー、腸障害）市場規模、用途別（製薬会社、病院、栄養クリニック、学術研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別吸収不良症候群の競争状況、市場シェア ・世界の吸収不良症候群市場：種類別市場規模 2015年-2020年（乳糖不耐症、嚢胞性線維症、ウィップル病、寄生虫症、熱帯性スプルー、腸障害） ・世界の吸収不良症候群市場：種類別市場規模予測 2021年-2026年（乳糖不耐症、嚢胞性線維症、ウィップル病、寄生虫症、熱帯性スプルー、腸障害） ・世界の吸収不良症候群市場：用途別市場規模 2015年-2020年（製薬会社、病院、栄養クリニック、学術研究所） ・世界の吸収不良症候群市場：用途別市場規模予測 2021年-2026年（製薬会社、病院、栄養クリニック、学術研究所） ・北米の吸収不良症候群市場分析：米国、カナダ ・ヨーロッパの吸収不良症候群市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの吸収不良症候群市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の吸収不良症候群市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの吸収不良症候群市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbvie、Actelion Pharmaceuticals、Astrazeneca、Bayer Healthcare、Dsm、Eli Lily And Company、Gilead Sciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Malabsorption syndrome refers to a number of disorders in which the small intestine can’t absorb enough of certain nutrients and fluids. These nutrients can be macronutrients (proteins, carbohydrates, and fats), micronutrients (vitamins and minerals), or both.
Treatment of Malabsorption is directed largely towards management of underlying cause. Replacement of nutrients, electrolytes and fluid may be necessary. In severe deficiency, hospital admission may be required for nutritional support and detailed advice from dietitians. Use of enteral nutrition by naso-gastric or other feeding tubes may be able to provide sufficient nutritional supplementation. Pancreatic enzymes are supplemented orally in pancreatic insufficiency. Dietary modification is important in some conditions including Gluten-free diet in coeliac disease and Lactose avoidance in lactose intolerance. Antibiotic therapy is used to treat Small Bowel Bacterial overgrowth.
Market Analysis and Insights: Global Malabsorption Syndrome Market
The global Malabsorption Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Malabsorption Syndrome Scope and Market Size
Malabsorption Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Malabsorption Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbvie
Actelion Pharmaceuticals
Astrazeneca
Bayer Healthcare
Dsm
Eli Lily And Company
Gilead Sciences
…
Market segment by Type, the product can be split into
Lactose Intolerance
Cystic Fibrosis
Whipple’s Disease
Parasitic Diseases
Tropical Sprue
Intestinal Disorders
Market segment by Application, split into
Pharmaceutical Companies
Hospitals
Nutrition Clinics
Academic And Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Malabsorption Syndrome Revenue
1.4 Market by Type
1.4.1 Global Malabsorption Syndrome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lactose Intolerance
1.4.3 Cystic Fibrosis
1.4.4 Whipple’s Disease
1.4.5 Parasitic Diseases
1.4.6 Tropical Sprue
1.4.7 Intestinal Disorders
1.5 Market by Application
1.5.1 Global Malabsorption Syndrome Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Companies
1.5.3 Hospitals
1.5.4 Nutrition Clinics
1.5.5 Academic And Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Malabsorption Syndrome Market Perspective (2015-2026)
2.2 Global Malabsorption Syndrome Growth Trends by Regions
2.2.1 Malabsorption Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Malabsorption Syndrome Historic Market Share by Regions (2015-2020)
2.2.3 Malabsorption Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Malabsorption Syndrome Market Growth Strategy
2.3.6 Primary Interviews with Key Malabsorption Syndrome Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Malabsorption Syndrome Players by Market Size
3.1.1 Global Top Malabsorption Syndrome Players by Revenue (2015-2020)
3.1.2 Global Malabsorption Syndrome Revenue Market Share by Players (2015-2020)
3.1.3 Global Malabsorption Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Malabsorption Syndrome Market Concentration Ratio
3.2.1 Global Malabsorption Syndrome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Malabsorption Syndrome Revenue in 2019
3.3 Malabsorption Syndrome Key Players Head office and Area Served
3.4 Key Players Malabsorption Syndrome Product Solution and Service
3.5 Date of Enter into Malabsorption Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Malabsorption Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Malabsorption Syndrome Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Malabsorption Syndrome Market Size by Application (2015-2020)
5.2 Global Malabsorption Syndrome Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Malabsorption Syndrome Market Size (2015-2020)
6.2 Malabsorption Syndrome Key Players in North America (2019-2020)
6.3 North America Malabsorption Syndrome Market Size by Type (2015-2020)
6.4 North America Malabsorption Syndrome Market Size by Application (2015-2020)
7 Europe
7.1 Europe Malabsorption Syndrome Market Size (2015-2020)
7.2 Malabsorption Syndrome Key Players in Europe (2019-2020)
7.3 Europe Malabsorption Syndrome Market Size by Type (2015-2020)
7.4 Europe Malabsorption Syndrome Market Size by Application (2015-2020)
8 China
8.1 China Malabsorption Syndrome Market Size (2015-2020)
8.2 Malabsorption Syndrome Key Players in China (2019-2020)
8.3 China Malabsorption Syndrome Market Size by Type (2015-2020)
8.4 China Malabsorption Syndrome Market Size by Application (2015-2020)
9 Japan
9.1 Japan Malabsorption Syndrome Market Size (2015-2020)
9.2 Malabsorption Syndrome Key Players in Japan (2019-2020)
9.3 Japan Malabsorption Syndrome Market Size by Type (2015-2020)
9.4 Japan Malabsorption Syndrome Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Malabsorption Syndrome Market Size (2015-2020)
10.2 Malabsorption Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Malabsorption Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Malabsorption Syndrome Market Size by Application (2015-2020)
11 India
11.1 India Malabsorption Syndrome Market Size (2015-2020)
11.2 Malabsorption Syndrome Key Players in India (2019-2020)
11.3 India Malabsorption Syndrome Market Size by Type (2015-2020)
11.4 India Malabsorption Syndrome Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Malabsorption Syndrome Market Size (2015-2020)
12.2 Malabsorption Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Malabsorption Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Malabsorption Syndrome Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview
13.1.3 Abbvie Malabsorption Syndrome Introduction
13.1.4 Abbvie Revenue in Malabsorption Syndrome Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Actelion Pharmaceuticals
13.2.1 Actelion Pharmaceuticals Company Details
13.2.2 Actelion Pharmaceuticals Business Overview
13.2.3 Actelion Pharmaceuticals Malabsorption Syndrome Introduction
13.2.4 Actelion Pharmaceuticals Revenue in Malabsorption Syndrome Business (2015-2020)
13.2.5 Actelion Pharmaceuticals Recent Development
13.3 Astrazeneca
13.3.1 Astrazeneca Company Details
13.3.2 Astrazeneca Business Overview
13.3.3 Astrazeneca Malabsorption Syndrome Introduction
13.3.4 Astrazeneca Revenue in Malabsorption Syndrome Business (2015-2020)
13.3.5 Astrazeneca Recent Development
13.4 Bayer Healthcare
13.4.1 Bayer Healthcare Company Details
13.4.2 Bayer Healthcare Business Overview
13.4.3 Bayer Healthcare Malabsorption Syndrome Introduction
13.4.4 Bayer Healthcare Revenue in Malabsorption Syndrome Business (2015-2020)
13.4.5 Bayer Healthcare Recent Development
13.5 Dsm
13.5.1 Dsm Company Details
13.5.2 Dsm Business Overview
13.5.3 Dsm Malabsorption Syndrome Introduction
13.5.4 Dsm Revenue in Malabsorption Syndrome Business (2015-2020)
13.5.5 Dsm Recent Development
13.6 Eli Lily And Company
13.6.1 Eli Lily And Company Company Details
13.6.2 Eli Lily And Company Business Overview
13.6.3 Eli Lily And Company Malabsorption Syndrome Introduction
13.6.4 Eli Lily And Company Revenue in Malabsorption Syndrome Business (2015-2020)
13.6.5 Eli Lily And Company Recent Development
13.7 Gilead Sciences
13.7.1 Gilead Sciences Company Details
13.7.2 Gilead Sciences Business Overview
13.7.3 Gilead Sciences Malabsorption Syndrome Introduction
13.7.4 Gilead Sciences Revenue in Malabsorption Syndrome Business (2015-2020)
13.7.5 Gilead Sciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Malabsorption Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Malabsorption Syndrome Revenue
Table 3. Ranking of Global Top Malabsorption Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Malabsorption Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lactose Intolerance
Table 6. Key Players of Cystic Fibrosis
Table 7. Key Players of Whipple’s Disease
Table 8. Key Players of Parasitic Diseases
Table 9. Key Players of Tropical Sprue
Table 10. Key Players of Intestinal Disorders
Table 11. Global Malabsorption Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Malabsorption Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Malabsorption Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Malabsorption Syndrome Market Share by Regions (2015-2020)
Table 15. Global Malabsorption Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Malabsorption Syndrome Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Malabsorption Syndrome Market Growth Strategy
Table 21. Main Points Interviewed from Key Malabsorption Syndrome Players
Table 22. Global Malabsorption Syndrome Revenue by Players (2015-2020) (Million US$)
Table 23. Global Malabsorption Syndrome Market Share by Players (2015-2020)
Table 24. Global Top Malabsorption Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malabsorption Syndrome as of 2019)
Table 25. Global Malabsorption Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Malabsorption Syndrome Product Solution and Service
Table 28. Date of Enter into Malabsorption Syndrome Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Malabsorption Syndrome Market Size by Type (2015-2020) (Million US$)
Table 31. Global Malabsorption Syndrome Market Size Share by Type (2015-2020)
Table 32. Global Malabsorption Syndrome Revenue Market Share by Type (2021-2026)
Table 33. Global Malabsorption Syndrome Market Size Share by Application (2015-2020)
Table 34. Global Malabsorption Syndrome Market Size by Application (2015-2020) (Million US$)
Table 35. Global Malabsorption Syndrome Market Size Share by Application (2021-2026)
Table 36. North America Key Players Malabsorption Syndrome Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Malabsorption Syndrome Market Share (2019-2020)
Table 38. North America Malabsorption Syndrome Market Size by Type (2015-2020) (Million US$)
Table 39. North America Malabsorption Syndrome Market Share by Type (2015-2020)
Table 40. North America Malabsorption Syndrome Market Size by Application (2015-2020) (Million US$)
Table 41. North America Malabsorption Syndrome Market Share by Application (2015-2020)
Table 42. Europe Key Players Malabsorption Syndrome Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Malabsorption Syndrome Market Share (2019-2020)
Table 44. Europe Malabsorption Syndrome Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Malabsorption Syndrome Market Share by Type (2015-2020)
Table 46. Europe Malabsorption Syndrome Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Malabsorption Syndrome Market Share by Application (2015-2020)
Table 48. China Key Players Malabsorption Syndrome Revenue (2019-2020) (Million US$)
Table 49. China Key Players Malabsorption Syndrome Market Share (2019-2020)
Table 50. China Malabsorption Syndrome Market Size by Type (2015-2020) (Million US$)
Table 51. China Malabsorption Syndrome Market Share by Type (2015-2020)
Table 52. China Malabsorption Syndrome Market Size by Application (2015-2020) (Million US$)
Table 53. China Malabsorption Syndrome Market Share by Application (2015-2020)
Table 54. Japan Key Players Malabsorption Syndrome Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Malabsorption Syndrome Market Share (2019-2020)
Table 56. Japan Malabsorption Syndrome Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Malabsorption Syndrome Market Share by Type (2015-2020)
Table 58. Japan Malabsorption Syndrome Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Malabsorption Syndrome Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Malabsorption Syndrome Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Malabsorption Syndrome Market Share (2019-2020)
Table 62. Southeast Asia Malabsorption Syndrome Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Malabsorption Syndrome Market Share by Type (2015-2020)
Table 64. Southeast Asia Malabsorption Syndrome Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Malabsorption Syndrome Market Share by Application (2015-2020)
Table 66. India Key Players Malabsorption Syndrome Revenue (2019-2020) (Million US$)
Table 67. India Key Players Malabsorption Syndrome Market Share (2019-2020)
Table 68. India Malabsorption Syndrome Market Size by Type (2015-2020) (Million US$)
Table 69. India Malabsorption Syndrome Market Share by Type (2015-2020)
Table 70. India Malabsorption Syndrome Market Size by Application (2015-2020) (Million US$)
Table 71. India Malabsorption Syndrome Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Malabsorption Syndrome Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Malabsorption Syndrome Market Share (2019-2020)
Table 74. Central & South America Malabsorption Syndrome Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Malabsorption Syndrome Market Share by Type (2015-2020)
Table 76. Central & South America Malabsorption Syndrome Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Malabsorption Syndrome Market Share by Application (2015-2020)
Table 78. Abbvie Company Details
Table 79. Abbvie Business Overview
Table 80. Abbvie Product
Table 81. Abbvie Revenue in Malabsorption Syndrome Business (2015-2020) (Million US$)
Table 82. Abbvie Recent Development
Table 83. Actelion Pharmaceuticals Company Details
Table 84. Actelion Pharmaceuticals Business Overview
Table 85. Actelion Pharmaceuticals Product
Table 86. Actelion Pharmaceuticals Revenue in Malabsorption Syndrome Business (2015-2020) (Million US$)
Table 87. Actelion Pharmaceuticals Recent Development
Table 88. Astrazeneca Company Details
Table 89. Astrazeneca Business Overview
Table 90. Astrazeneca Product
Table 91. Astrazeneca Revenue in Malabsorption Syndrome Business (2015-2020) (Million US$)
Table 92. Astrazeneca Recent Development
Table 93. Bayer Healthcare Company Details
Table 94. Bayer Healthcare Business Overview
Table 95. Bayer Healthcare Product
Table 96. Bayer Healthcare Revenue in Malabsorption Syndrome Business (2015-2020) (Million US$)
Table 97. Bayer Healthcare Recent Development
Table 98. Dsm Company Details
Table 99. Dsm Business Overview
Table 100. Dsm Product
Table 101. Dsm Revenue in Malabsorption Syndrome Business (2015-2020) (Million US$)
Table 102. Dsm Recent Development
Table 103. Eli Lily And Company Company Details
Table 104. Eli Lily And Company Business Overview
Table 105. Eli Lily And Company Product
Table 106. Eli Lily And Company Revenue in Malabsorption Syndrome Business (2015-2020) (Million US$)
Table 107. Eli Lily And Company Recent Development
Table 108. Gilead Sciences Company Details
Table 109. Gilead Sciences Business Overview
Table 110. Gilead Sciences Product
Table 111. Gilead Sciences Revenue in Malabsorption Syndrome Business (2015-2020) (Million US$)
Table 112. Gilead Sciences Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Malabsorption Syndrome Market Share by Type: 2020 VS 2026
Figure 2. Lactose Intolerance Features
Figure 3. Cystic Fibrosis Features
Figure 4. Whipple’s Disease Features
Figure 5. Parasitic Diseases Features
Figure 6. Tropical Sprue Features
Figure 7. Intestinal Disorders Features
Figure 8. Global Malabsorption Syndrome Market Share by Application: 2020 VS 2026
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Nutrition Clinics Case Studies
Figure 12. Academic And Research Institutes Case Studies
Figure 13. Malabsorption Syndrome Report Years Considered
Figure 14. Global Malabsorption Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Malabsorption Syndrome Market Share by Regions: 2020 VS 2026
Figure 16. Global Malabsorption Syndrome Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Malabsorption Syndrome Market Share by Players in 2019
Figure 19. Global Top Malabsorption Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malabsorption Syndrome as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Malabsorption Syndrome Revenue in 2019
Figure 21. North America Malabsorption Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Malabsorption Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Malabsorption Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Malabsorption Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Malabsorption Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Malabsorption Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Malabsorption Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
多嚢胞性卵巣症候群治療の世界市場（～2026年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…- カルチノイド症候群管理の世界市場（～2026年） Carcinoid syndrome comprises of signs and symptoms including flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are settled secondary to carcinoid tumor. The manage…
- シェーグレン症候群治療薬の世界市場（～2026年） Sjogren’s syndrome is an inflammatory disorder characterized by lymphocytic infiltrates in exocrine organs, primarily in lacrimal and salivary glands, resulting in classic sicca symptoms of dry mouth (xerostomia) and dry eyes (xerophthalmia). The disorder segmented into primary and secondary. The di…
- 間欠的発熱症候群の世界市場（～2026年） Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation. The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. Market …
- ギランバレー症候群の世界市場（～2026年） Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system. Market Analysis and Insights: Global Guillain-Barré Syndrome Market The global Guillain-Barré Syndrome market size is projected to reach US$ 449.2 million by 2026, from US$ 43…